Market Tracker

12/08 1:14pm ET

Amicus Therapeutics Inc (NASDAQ:FOLD)

5.94
BATS BZX Real-Time Price
As of 1:14pm ET
 +0.08 / +1.37%
Today’s Change
4.98
Today|||52-Week Range
10.12
-38.76%
Year-to-Date
The Latest Buzz in Biotech
Dec 06 / MotleyFool.com - Paid Partner Content
Amicus Provides Regulatory Update on Fabry Disease Drug
Nov 29 / Zacks.com - Paid Partner Content
Biotech's Dumbest CEO Moves in 2016
Dec 05 / MotleyFool.com - Paid Partner Content
Why Amicus Therapeutics Shares Are Crashing 21.8% Today
Nov 29 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.86
Today’s open5.96
Day’s range5.81 - 6.13
Volume128,807
Average volume (3 months)2,382,440
Market cap$868.2M
Dividend yield--
Data as of 1:14pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-29.03%
Earnings growth (this year)-16.99%
Earnings growth (next 5 years)+38.44%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.11-1.38%
LCILannett Company Inc+0.90+3.87%
ZIOPZIOPHARM Oncology In...-0.28-4.29%
INSMInsmed Inc-0.15-1.20%
Data as of 1:14pm ET, 12/08/2016

Financials

Next reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$132.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts